NAFDAC Approves ABUAD Herbal Drug For COVID-19

The National Agency for Food and Drug Administration and Control (NAFDAC) has approved a herbal drug developed by Afe Babalola University, Ado-Ekiti (ABUAD) for treatment of COVID-19.

The founder of the University, Afe Babalola who made this known on Tuesday, said the drug had been tested on 19 COVID-19 patients and have all recovered.

He said the number of those cured by the herbal drug has increased since its approval a few weeks ago by NAFDAC. Babalola noted that the research department of the university over the years has made meaningful discoveries aimed at solving the socio-economic problems of the country.

Babalola, a Senior Advocate of Nigeria (SAN) and Educationist, spoke on Tuesday in Ado-Ekiti, the Ekiti state capital, at a ceremony commemorating the 12th anniversary of the establishment of ABUAD.

He said he conceived the institution in 2010 to contribute to the nation’s education development in the area of research, teaching and community service.“

I am happy that I conceived this university twelve years ago and since then, we have been going from strength to strength, making exploits in all our endeavors. Our vision is to make this place a great institution in the university education in the country in teaching, research and community service.

“I can confirm to you today that our herbal drug produced through extensive research by our team of researchers has healed about 19 patients who contracted covid-19 pandemic. They were healed perfectly less than five days of usage, that tells you the level of our research in ABUAD”, he said.